We are live on ! Find out more
TCRT icon

Alaunos Therapeutics
TCRT

142 hedge funds and large institutions have $354M invested in Alaunos Therapeutics in 2019 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 32 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 32

10% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 20

1% more funds holding

Funds holding: 140 → 142 (+2)

0.05% more ownership

Funds ownership: 0.29% → 0.34% (+0.05%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less capital invested

Capital invested by funds: $409M → $354M (-$55.3M)

36% less call options, than puts

Call options by funds: $6.68M | Put options by funds: $10.5M

Holders
142
Holders Change
+2
Holders Change %
+1.43%
% of All Funds
3.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
48
Reduced
32
Closed
20
Calls
$6.68M
Puts
$10.5M
Net Calls
-$3.81M
Net Calls Change
+$1.08M

Top Buyers

Rank Fund Capital Flow
1
MP
MSD Partners
New York
+$22M
2
MVP
Miller Value Partners
Florida
+$19.8M
3
State Street
State Street
Massachusetts
+$8.3M
4
DCM
Discovery Capital Management
Connecticut
+$7.61M
5
BlackRock
BlackRock
New York
+$2.81M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$2.6M
2
SG Americas Securities
SG Americas Securities
New York
-$2.21M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.29M
4
Barclays
Barclays
United Kingdom
-$589K
5
CSS
Cubist Systematic Strategies
Connecticut
-$564K
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
76
Advisor Group
Arizona
$174K -$11.1K -14 -5%
PPA
77
Parametric Portfolio Associates
Washington
$160K +$49.2K +62 +33%
Legal & General Group
78
Legal & General Group
United Kingdom
$158K +$32.5K +41 +20%
HF
79
HRT Financial
New York
$158K +$196K +247 New
LI
80
Leap Investments
Illinois
$149K +$183K +231 New
Victory Capital Management
81
Victory Capital Management
Texas
$149K +$185K +233 New
Mitsubishi UFJ Asset Management
82
Mitsubishi UFJ Asset Management
Japan
$145K +$34.9K +44 +24%
IAM
83
Iridian Asset Management
Connecticut
$145K +$179K +226 New
SI
84
Stephens Inc
Arkansas
$137K -$7.14K -9 -4%
PNC Financial Services Group
85
PNC Financial Services Group
Pennsylvania
$130K +$132K +166 +461%
OC
86
Oppenheimer & Co
New York
$125K +$4.76K +6 +3%
AB
87
Amalgamated Bank
New York
$122K -$1.59K -2 -1%
GJIC
88
Gamble Jones Investment Counsel
California
$120K – – –
Public Employees Retirement Association of Colorado
89
Public Employees Retirement Association of Colorado
Colorado
$119K – – –
BNP Paribas Financial Markets
90
BNP Paribas Financial Markets
France
$117K +$55.5K +70 +62%
Russell Investments Group
91
Russell Investments Group
United Kingdom
$114K +$140K +177 New
DIM
92
Delta Investment Management
California
$110K +$137K +173 New
VF
93
Virtu Financial
New York
$105K -$178K -224 -58%
Squarepoint
94
Squarepoint
New York
$103K +$128K +161 New
SPIA
95
Steward Partners Investment Advisory
New York
$101K -$9.52K -12 -7%
Royal Bank of Canada
96
Royal Bank of Canada
Ontario, Canada
$90K -$53.9K -68 -33%
ACM
97
Allred Capital Management
Texas
$88K – – –
DHFB
98
Dixon Hubard Feinour & Brown
Virginia
$84K – – –
ProShare Advisors
99
ProShare Advisors
Maryland
$78K +$23K +29 +31%
BCM
100
BlueCrest Capital Management
Jersey
$78K +$96.8K +122 New
2 3
4
5 6

TCRT Hedge Fund Activity: Q3 2019 in Review

142 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q3 2019, worth a combined $354M — down 14% from $409M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new TCRT positions and 20 closed out — a net gain of 2 holders — while 48 added to existing stakes and 32 trimmed.

The largest buyer was MSD Partners, adding an estimated $22M. The largest seller was Invesco, exiting entirely with an estimated $2.6M sold.

  • 142 institutional investors held Alaunos Therapeutics (TCRT) as of Q3 2019, up from 140 in Q2 2019.
  • Funds reported $354M of Alaunos Therapeutics stock for Q3 2019, down 14% quarter-over-quarter.
  • 22 funds opened new Alaunos Therapeutics positions in Q3 2019 and 20 closed out, a net change of +2 holders.
  • The largest Alaunos Therapeutics buyer in Q3 2019 was MSD Partners, an estimated $22M added.
  • The largest Alaunos Therapeutics seller in Q3 2019 was Invesco, an estimated $2.6M sold.

Based on aggregated 13F filings for Q3 2019.